Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in

Anna K. Nowak, W. Joost Lesterhuis, Peey Sei Kok, Chris Brown, Brett GM Hughes, Deme J. Karikios, Thomas John, Steven C.H. Kao, Connull Leslie, Alistair M. Cook, Nick Pavlakis, Karen Briscoe, Kenneth J. O'Byrne, Christos S. Karapetis, Wei Sen Lam, Ailsa Langford, Sonia Yip, Martin R. Stockler

Research output: Contribution to journalArticlepeer-review

32 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in'. Together they form a unique fingerprint.

Medicine & Life Sciences